Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis

This publication has 26 references indexed in Scilit:

• To cycle or not to cycle: a critical decision in cancer
  Nature Reviews Cancer, 2001
• Effect of Arsenic Trioxide on Cell Cycle Arrest in Head and Neck Cancer Cell Line PCI-1
  Biochemical and Biophysical Research Communications, 1999
• Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
  New England Journal of Medicine, 1998
• The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms
  Leukemia, 1998
• Arsenic Trioxide and Melarsoprol Induce Programmed Cell Death in Myeloid Leukemia Cell Lines and Function in a PML and PML-RAR Independent Manner
  Blood, 1998
• Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RARα Protein in Acute Promyelocytic Leukemia Cells
  JNCI Journal of the National Cancer Institute, 1998
• Cancer Cell Cycles
  Science, 1996
• In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins
  Blood, 1996
• Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex
  Nature, 1995
• Metal carcinogenesis: Mechanistic implications
  Pharmacology & Therapeutics, 1992